| • | | A Registration and Stockholder Rights Agreement, dated November 11, 2021, by and among the Company, the Sponsor, and certain other security holders of the Company, a copy of which is attached as Exhibit 10.3 hereto and incorporated herein by reference. |
| • | | A Private Placement Warrants Purchase Agreement, dated November 11, 2021 (the “Private Placement Warrants Purchase Agreement”), by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.4 hereto and incorporated herein by reference. |
| • | | An Administrative Support Agreement, dated November 11, 2021, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.5 hereto and incorporated herein by reference. |
| • | | An Indemnity Agreement, dated November 11, 2021, by and between the Company and Richard D. Bertel, a copy of which is attached as Exhibit 10.6 hereto and incorporated herein by reference. |
| • | | An Indemnity Agreement, dated November 11, 2021, by and between the Company and Mark A. Michel, a copy of which is attached as Exhibit 10.7 hereto and incorporated herein by reference. |
| • | | An Indemnity Agreement, dated November 11, 2021, by and between the Company and Chris A. Bertel a copy of which is attached as Exhibit 10.8 hereto and incorporated herein by reference. |
| • | | An Indemnity Agreement, dated November 11, 2021, by and between the Company and Timothy J. Fisher, a copy of which is attached as Exhibit 10.9 hereto and incorporated herein by reference. |
| • | | An Indemnity Agreement, dated November 11, 2021, by and between the Company and Nathan Asplund, a copy of which is attached as Exhibit 10.10 hereto and incorporated herein by reference. |
| • | | An Indemnity Agreement, dated November 11, 2021, by and between the Company and Rollin D. Bredenberg, a copy of which is attached as Exhibit 10.11 hereto and incorporated herein by reference. |
| • | | An Indemnity Agreement, dated November 11, 2021, by and between the Company and Brian M. Feldott, a copy of which is attached as Exhibit 10.12 hereto and incorporated herein by reference. |
| • | | An Indemnity Agreement, dated November 11, 2021, by and between the Company and Edmund Underwood, Jr., a copy of which is attached as Exhibit 10.13 hereto and incorporated herein by reference. |
| • | | An Indemnity Agreement, dated November 11, 2021, by and between the Company and Robert Bach, a copy of which is attached as Exhibit 10.14 hereto and incorporated herein by reference. |
| • | | An Indemnity Agreement, dated November 11, 2021, by and between the Company and Mark Hemphill, a copy of which is attached as Exhibit 10.15 hereto and incorporated herein by reference. |
| • | | An Indemnity Agreement, dated November 11, 2021, by and between the Company and Michael Haeg, a copy of which is attached as Exhibit 10.16 hereto and incorporated herein by reference. |
Item 3.02. Unregistered Sales of Equity Securities.
Simultaneously with the closing of the IPO, pursuant to the Private Placement Warrants Purchase Agreement, the Company completed the private sale of an aggregate of 9,400,000 warrants (the “Private Placement Warrants”), including 900,000 Private Placement Warrants issued pursuant to the underwriters’ exercise of their over-allotment option in full, to the Sponsor at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $9,400,000. The Private Placement Warrants are identical to the Warrants included in the Units sold as part of the Units in the IPO, except as otherwise disclosed in the Registration Statement. No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On November 11, 2021 and in connection with the IPO, Mark A. Michel, Timothy J. Fisher, Nathan Asplund, Rollin D. Bredenberg, Brian M. Feldott, and Edmund Underwood, Jr. (the “Directors”) were appointed to the board of directors of the Company (the “Board”). Messrs. Asplund, Bredenberg and Feldott are independent directors.
Effective November 11, 2021, Messrs. Feldott, Asplund and Bredenberg were appointed to the Board’s audit committee, with Mr. Feldott serving as chair. Effective November 11, 2021, Messrs. Bredenberg and Feldott were appointed to the Board’s compensation committee, with Mr. Bredenberg serving as chair. Effective November 11, 2021, Messrs. Feldott, Asplund and Bredenberg were appointed to the Board’s nominating and corporate governance committee, with Mr. Bredenberg serving as chair.
Following the appointment of the Directors, the Board is comprised of the following three classes: the term of office of the first class of directors, consisting of Messrs. Michel and Fisher, will expire at the Company’s first annual meeting of stockholders; the term of office of the second class of directors, consisting of Messrs. Feldott and Underwood, Jr., will expire at the Company’s second annual meeting of stockholders; and the term of office of the third class of directors, consisting of Messrs. Bertel, Bredenberg and Asplund, will expire at the Company’s third annual meeting of stockholders.
On November 11, 2021, in connection with their appointments to the Board, each Director entered into the Letter Agreement as well as the Indemnity Agreement with the Company.
Other than the foregoing, none of the Directors are party to any arrangement or understanding with any person pursuant to which they were appointed as directors, nor are they party to any transactions required to be disclosed under Item 404(a) of Regulation S-K involving the Company.
The foregoing descriptions of the Letter Agreement and the Indemnity Agreements do not purport to be complete and are qualified in their entireties by reference to the Letter Agreement and Indemnity Agreements, copies of which are attached as Exhibit 10.1 hereto and Exhibit 10.6 - 10.16, respectively, and are incorporated herein by reference.